Search Results - "Pilhatsch, M"

Levothyroxine effects on depressive symptoms and limbic glucose metabolism in bipolar disorder: a randomized, placebo-controlled positron emission tomography study by Bauer, M, Berman, S, Stamm, T, Plotkin, M, Adli, M, Pilhatsch, M, London, E D, Hellemann, G S, Whybrow, P C, Schlagenhauf, F

“…Adding supraphysiologic doses of levothyroxine (L-T4) to standard treatment for bipolar depression shows promise, but the mechanisms underlying clinical…”
Get full text

Antibodies in autoimmune thyroiditis affect glucose metabolism of anterior cingulate by Pilhatsch, M, Schlagenhauf, F, Silverman, D, Berman, S, London, E.D, Martinez, D, Whybrow, P.C, Bauer, M

“…Highlight • Autoimmune processes may play a critical role in poorly defined correlates of disturbed function in affect regulating brain regions in…”
Get full text

Influence of levothyroxine in augmentation therapy for bipolar depression on central serotonergic function by Uhl, I, Bez, J A, Stamm, T, Pilhatsch, M, Assion, H-J, Norra, C, Lewitzka, U, Schlagenhauf, F, Bauer, M, Juckel, G

“…Adjunctive treatment with supraphysiological doses of levothyroxine (L-T4) in bipolar depression shows promise, but the neurobiological mechanisms underlying…”
Get more information

Regularity in daily mood stabilizer dosage taken by patients with bipolar disorder by Bauer, M, Glenn, T, Alda, M, Sagduyu, K, Marsh, W, Grof, P, Munoz, R, Baethge, C, Lewitzka, U, Pilhatsch, M, Bauer, R, Whybrow, P C

“…The aim of this study was to investigate regularity in the daily mood stabilizer dosage taken by patients with bipolar disorder, and identify factors…”
Get more information

Is there an increased risk for renal tumors during long-term treatment with lithium? by Conell, J, Lewitzka, U, Ritter, P, Severus, E, Pilhatsch, M, Pfennig, A, Berghöfer, M, Bauer, M

“…Lithium salts are the recommended first-line treatment (gold standard) in national and international treatment guidelines for acute and maintenance treatment…”
Get full text

Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression by Adli, M, Pilhatsch, M, Bauer, M, Köberle, U, Ricken, R, Janssen, G, Ulrich, S, Bschor, T

“…Because the irreversible monoamine oxidase inhibitor tranylcypromine (TCP) was introduced nearly 50 years ago, only few studies exist on today's clinical…”
Get more information

P.1.e.001 Neural substrates of fear conditioning and extinction recall in a delayed extinction task by Lueken, U, Maslowski, N.I, Wittmann, A, Pilhatsch, M, Wittchen, H.U

Get full text

P.2.e.027 Supraphysiological doses of levothyroxine in bipolar depression: a randomised controlled, double blind study by Stamm, T, Adli, M, Koeberle, U, Pilhatsch, M, Sauer, C, Whybrow, P, Frye, M, Bauer, M

Get full text

Augmentation with atomoxetine in treatment-resistant depression with psychotic features. A case report by Pilhatsch, M K, Burghardt, R, Wandinger, K-P, Bauer, M, Adli, M

Get more information

Specific aspects of treatment for women with bipolar affliction by Sasse, J, Pilhatsch, M, Forsthoff, A, Grunze, H, Neutze, J, Pfennig, A, Schmitz, B, Schwenkhagen, A, Bauer, M

“…This manuscript summarizes specific issues in the disease course and pharmacological treatment of women with bipolar disorders. Gender differences relevant to…”
Get full text

Association between solar insolation and a history of suicide attempts in bipolar I disorder by Bauer, Michael, Glenn, Tasha, Alda, Martin, Andreassen, Ole A., Angelopoulos, Elias, Ardau, Raffaella, Ayhan, Yavuz, Baethge, Christopher, Bauer, Rita, Baune, Bernhard T., Becerra-Palars, Claudia, Bellivier, Frank, Belmaker, Robert H., Bersudsky, Yuly, Bicakci, Şule, Birabwa-Oketcho, Harriet, Bjella, Thomas D., Cabrera, Jorge, Wo Cheung, Eric Y., Del Zompo, Maria, Dodd, Seetal, Donix, Markus, Etain, Bruno, Fagiolini, Andrea, Fountoulakis, Kostas N., Frye, Mark A., Gonzalez-Pinto, Ana, Gottlieb, John F., Grof, Paul, Harima, Hirohiko, Henry, Chantal, Isometsä, Erkki T., Janno, Sven, Kardell, Mathias, Khaldi, Slim, Kliwicki, Sebastian, König, Barbara, Kot, Timur L., Krogh, Rikke, Kunz, Mauricio, Lafer, Beny, Landén, Mikael, Larsen, Erik R., Lewitzka, Ute, Lopez-Jaramillo, Carlos, MacQueen, Glenda, Manchia, Mirko, Marsh, Wendy, Martinez-Cengotitabengoa, Mónica, Melle, Ingrid, Meza-Urzúa, Fátima, Ming, Mok Yee, Monteith, Scott, Morken, Gunnar, Mozzhegorov, Anton A., Munoz, Rodrigo, Mythri, Starlin V., Nacef, Fethi, Nadella, Ravi K., Nery, Fabiano G., Nielsen, René E., O'Donovan, Claire, Omrani, Adel, Osher, Yamima, Sørensen, Helle Østermark, Ouali, Uta, Ruiz, Yolanda Pica, Pilhatsch, Maximilian, Pinna, Marco, da Ponte, Francisco D.R., Quiroz, Danilo, Ramesar, Raj, Rasgon, Natalie, Reddy, M.S., Reif, Andreas, Ritter, Philipp, Rybakowski, Janusz K., Sagduyu, Kemal, Raghuraman, Bharathram Sathur, Scippa, Ângela M., Severus, Emanuel, Simhandl, Christian, Stackhouse, Paul W., Stein, Dan J., Strejilevich, Sergio, Subramaniam, Mythily, Sulaiman, Ahmad Hatim, Suominen, Kirsi, Tagata, Hiromi, Tatebayashi, Yoshitaka, Tondo, Leonardo, Torrent, Carla, Vaaler, Arne E., Vares, Edgar, Veeh, Julia, Viswanath, Biju, Yoldi-Negrete, Maria, Zetin, Mark, Zgueb, Yosra, Whybrow, Peter C.

“…In many international studies, rates of completed suicide and suicide attempts have a seasonal pattern that peaks in spring or summer. This exploratory study…”
Get full text

Increased depressive behaviour in mice harboring the mutant thyroid hormone receptor alpha 1 by Pilhatsch, Maximilian, Winter, Christine, Nordström, Kristina, Vennström, Björn, Bauer, Michael, Juckel, Georg

“…Clinical evidence indicates that hypothyroidism contributes to mood disorders. The present study tested if the mutant thyroid hormone receptor alpha 1 (TRα1)…”
Get full text

Ketamine as antidepressant: the current study situation by Ritter, P S, Bauer, M, Pilhatsch, M

“…The treatment of depressive episodes is characterized by a delay in response of antidepressant medications and high rates of therapeutic failure. In recent…”
Get full text

Ketamin als Antidepressivum: Die aktuelle Studienlage by Ritter, P.S., Bauer, M., Pilhatsch, M.

“…Zusammenfassung Die Therapie depressiver Episoden ist durch einen verzögerten Wirkungseintritt antidepressiver Medikamente und hohe Raten therapierefraktärer…”
Get full text

Gibt es bei der Lithiumlangzeitbehandlung ein erhöhtes Risiko für Nierentumoren? by Conell, J., Lewitzka, U., Ritter, P., Severus, E., Pilhatsch, M., Pfennig, A., Berghöfer, M., Bauer, M.

“…Zusammenfassung Lithium wird aufgrund sehr gut belegter Wirksamkeit erfolgreich in der Akutbehandlung und Prophylaxe affektiver Erkrankungen, insbesondere…”
Get full text

Spezifische Behandlungsaspekte bipolar erkrankter Frauen by Sasse, J., Pilhatsch, M., Forsthoff, A., Grunze, H., Neutze, J., Pfennig, A., Schmitz, B., Schwenkhagen, A., Bauer, M.

“…Zusammenfassung Im vorliegenden Artikel werden Besonderheiten im Krankheitsverlauf und in der Pharmakotherapie bipolar erkrankter Frauen diskutiert…”
Get full text

Specific aspects of treatment for women with bipolar affliction by Sasse, J, Pilhatsch, M, sthoff, A, Grunze, H, Neutze, J, Pfennig, A, Schmitz, B, Schwenkhagen, A, Bauer, M

Get full text

Amygdala-Function Perturbations in Healthy Mid-Adolescents With Familial Liability for Depression by Pilhatsch, Maximilian, MD, Vetter, Nora C., PhD, Hübner, Thomas, PhD, Ripke, Stephan, PhD, Müller, Kathrin U., MSc, Marxen, Michael, PhD, Rodehacke, Sarah, MSc, Mennigen, Eva, MD, Schmidt, Dirk, MSC, Kroemer, Nils B., PhD, Smolka, Michael N., MD

“…Objective Functional magnetic resonance imaging (fMRI) studies have identified increased amygdala responses to negative stimuli as a risk marker of depression…”
Get full text